
🧬 Rafael Rosengarten - Part 2 | From Marine Biology to Synthetic Biology | Building Biofuel Tools at JBEI | When Academic Labs Embrace Entrepreneurship
Part 2 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for every target, drug, and patient using a combination of precision oncology, RNA, and AI. Rafael, a biomedical research veteran, combines academic excellence with industry innovation. A Dartmouth graduate with a Yale doctorate, he conducted postdoctoral research at Lawrence Berkeley National Laboratory, where he co-invented the j5 DNA assembly tool. As co-founder of the Alliance for AI in Healthcare, he advocates for responsible AI integration in medicine, drawing from his extensive background in evolution, immunology, bioengineering, and genetics.
The Biotech Startups Podcast · Excedr
Audio is streamed directly from the publisher (media.fame.so) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🔗 Get your unique referral link here: refer.excedr.com/ZTHETY.
Part 2 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for every target, drug, and patient using a combination of precision oncology, RNA, and AI.
In this episode, you'll hear about:
- Rafael's graduate studies at Yale, where mentors fostered his independent research approach
- His diverse marine biology and genomics projects, preparing him for synthetic biology
- Rafael's transition to the Joint BioEnergy Institute (JBEI) for synthetic biology and biofuels research
- The collaborative environment at JBEI, including access to cutting-edge technology and bioinformatics tool development
- Rafael's insights on choosing the right lab environment and the growing acceptance of entrepreneurship in academia